349 Development of a digital tool for home-based monitoring of skin disease for older adults

Egmond, S. van; Cai, Zhuo Ran; Nava, Vanessa; Rapaport, Bailie R.; Ko, Jin Hwan; Chiou, Albert S.; Sarin, Kavita Y.; Tang, Jingjing; Bousheri, S.; Zhang, L.; Linos, Eleni

doi:10.1016/j.jid.2022.05.358

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The array of digital health technologies available to support telemedicine delivery has also continued to mature, with the widespread availability of biosensors and communication platforms (eg, SMS text messaging platforms, chatbots, and mobile apps) and smartphone imaging, alongside transformative advancements in artificial intelligence. Many recent reports describe applications of these rapidly developing technologies in dermatology [4][5][6][7][8][9]. Attention is turning to quality, safety, and best practices in a sustained health care delivery model that incorporates telemedicine in a rapidly evolving landscape of digital health technologies.…”

Section: Introductionmentioning

confidence: 99%

Consensus Guidelines for Teledermatology: Scoping Review

Cummins¹,

Ong²,

Ivanova³

et al. 2023

JMIR Dermatol

View full text Add to dashboard Cite

Background Consensus guidelines and recommendations play an important role in fostering quality, safety, and best practices, as they represent an expert interpretation of the biomedical literature and its application to practice. However, it is unclear whether the recent collective experience of implementing telemedicine and the concurrent growth in the evidence base for teledermatology have resulted in more robust guidance. Objective The objective of this review was to describe the extent and nature of currently available guidance, defined as consensus guidelines and recommendations available for telemedicine in dermatology, with guidance defined as consensus or evidence-based guidelines, protocols, or recommendations. Methods We conducted a single-reviewer scoping review of the literature to assess the extent and nature of available guidance, consensus guidelines, or recommendations related to teledermatology. We limited the review to published material in English since 2013, reflecting approximately the past 10 years. We conducted the review in November and December of the year 2022. Results We identified 839 potentially eligible publications, with 9 additional records identified through organizational websites. A total of 15 publications met the inclusion and exclusion criteria. The guidelines focused on varied topics and populations about dermatology and skin diseases. However, the most frequent focus was general dermatology (8/15, 53%). Approximately half of the telemedicine guidance described in the publications was specific to dermatology practice in the context of the COVID-19 pandemic. The publications were largely published in or after the year 2020 (13/15, 87%). Geographical origin spanned several different nations, including Australia, the United States, European countries, and India. Conclusions We found an increase in COVID-19–specific teledermatology guidance during 2020, in addition to general teledermatology guidance during the period of the study. Primary sources of general teledermatology guidance reported in the biomedical literature are the University of Queensland’s Centre for Online Health and Australasian College of Dermatologists E-Health Committee, and the American Telemedicine Association. There is strong evidence of international engagement and interest. Despite the recent increase in research reports related to telemedicine, there is a relative lack of new guidance based on COVID-19 lessons and innovations. There is a need to review recent evidence and update existing recommendations. Additionally, there is a need for guidance that addresses emerging technologies.

show abstract

Section: Introductionmentioning

confidence: 99%

Consensus Guidelines for Teledermatology: Scoping Review

Cummins¹,

Ong²,

Ivanova³

et al. 2023

JMIR Dermatol

View full text Add to dashboard Cite

show abstract

Consensus Guidelines for Teledermatology: Scoping Review (Preprint)

Cummins¹,

Ong²,

Ivanova³

et al. 2023

Preprint

View full text Add to dashboard Cite

BACKGROUND Consensus guidelines and recommendations play an important role in fostering quality, safety, and best practices, as they represent an expert interpretation of the biomedical literature and its application to practice. However, it is unclear whether the recent collective experience of implementing telemedicine and the concurrent growth in the evidence base for teledermatology have resulted in more robust guidance. OBJECTIVE The objective of this review was to describe the extent and nature of currently available guidance, defined as consensus guidelines and recommendations, available for the practice of telemedicine in dermatology, with guidance defined as consensus or evidence-based guidelines, protocols, or recommendations. METHODS We conducted a single-reviewer scoping review of the literature to assess the extent and nature of available guidance, consensus guidelines, or recommendations related to teledermatology. We limited the review to published material in the English language, since 2013, reflecting approximately the past ten years. We conducted the review in November and December of 2022. RESULTS We identified 839 potentially eligible publications, with an additional nine records identified via a grey literature search. Fifteen publications met the inclusion and exclusion criteria. The guidelines focused on varied topics and populations concerning dermatology and skin diseases. However, the most frequent focus was general dermatology (53%). Approximately half of the telemedicine guidance described in the publications was specific to dermatology practice in the context of the COVID-19 pandemic, and the publications were largely published in or after the year 2020 (13/15, 87%). Geographical origin spanned several different nations, including Australia, the United States, European nations, and India. CONCLUSIONS We found an increase in COVID-19 specific teledermatology guidance during 2020, in addition to general teledermatology guidance during the time period of the study. Primary sources of general teledermatology guidance, reported in the biomedical literature, are the University of Queensland’s Centre for Online Health and Australasian College of Dermatologists E-Health Committee, and the American Telemedicine Association. There is strong evidence of international engagement and interest. Despite the recent increase in research reports related to telemedicine, there is a relative lack of new guidance based upon COVID-19 lessons and innovations. Clearly, there is a need to review recent evidence and update existing recommendations. Additionally, there is a need for guidance that addresses emerging technologies.

show abstract

349 Development of a digital tool for home-based monitoring of skin disease for older adults

Cited by 2 publications

References 0 publications

Consensus Guidelines for Teledermatology: Scoping Review

Consensus Guidelines for Teledermatology: Scoping Review

Consensus Guidelines for Teledermatology: Scoping Review (Preprint)

Contact Info

Product

Resources

About